London is Calling! Register here for ESHRE 2026!

In memoriam - Dr Stephan Gordts

ESHRE is deeply saddened by the passing of Dr. Stephan Gordts, a highly respected pioneer in reproductive surgery and a longstanding and valued member of our society. His scientific contributions, leadership, and dedication to education have left a lasting mark on reproductive medicine and on the ESHRE community.


Help shape our future recommendations

With several surveys and stakeholder reviews coming up, now is the perfect time to get involved and help shape future recommendations.

Discover how you can contribute.


New ESHRE Good Practice Recommendations paper ready for stakeholder feedback

Expanded Carrier Screening (ECS) for reproductive purposes is a genetic testing strategy intended to identify individuals or couples who carry pathogenic/likely pathogenic variants in genes associated with autosomal recessive (AR) or X-linked recessive (XLR) conditions.
The purpose of this paper is to establish good practice recommendations for the implementation of ECS in MAR centres, to promote standardised, ethical, and effective use that can support informed reproductive decision-making.
The Good Practice Recommendations paper is open for stakeholder review between 15 May and 12 June 2026.


Endocrine disrupting chemicals (EDCs): A hidden threat to fertility

On World Hormone Day, ESHRE is publishing an infographic on the harmful effects of endocrine disrupting chemicals (EDCs) on fertility, developed in collaboration with Fertility Europe and the European Society of Endocrinology.